Literature DB >> 10990233

MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia.

L Ricci-Vitiani1, A Vacca, I Potolicchio, R Scarpa, P Bitti, G Sebastiani, G Passiu, A Mathieu, R Sorrentino.   

Abstract

OBJECTIVE: We investigated the distribution of MICA triplet repeat polymorphism in a random population and in patients with seronegative spondyloarthritis from Sardinia compared to continental Italy.
METHODS: We analyzed the distribution of MICA triplet repeat polymorphism in HLA-B*2709 [not associated with ankylosing spondylitis (AS)] and B*2705 (associated with AS) haplotypes, to verify whether the strong association of MICA-A4 with HLA-B27 reported in other populations is maintained in Sardinia, and compared the distribution of MICA-A alleles in HLA-B27 negative versus HLA-B27+ patients with AS.
RESULTS: We found that the frequency of MICA-A4 triplet repeat allele in a random Sardinia population is higher (53.2%) than in other Caucasian populations (around 20%); this allele is strongly associated with both HLA-B*2709 and B*2705. No significant difference between HLA-B27+ patients with AS and healthy controls was found: the MICA-A4 allele was present in more than 90% of subjects. MICA-A4 was found in 16 out of 20 HLA-B27 negative Sardinian patients with AS, with a frequency (80%) more similar to that of the HLA-B27+ group of patients than that of controls.
CONCLUSION: The high frequency of MICA-A4 allele in HLA-B27 negative patients with AS from Sardinia, suggests the presence within the HLA region of a susceptibility factor other and certainly weaker than B27. This factor is likely to be more easily found by analyzing genetically homogeneous populations like the Sardinian, characterized by a small number of very frequent haplotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990233

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis.

Authors:  Y H Lee; S-C Bae; J-H Kim; G G Song
Journal:  Z Rheumatol       Date:  2015-03       Impact factor: 1.372

2.  Meta-analysis of functional MBL polymorphisms. Associations with rheumatoid arthritis and primary Sjögren's syndrome.

Authors:  G G Song; S-C Bae; Y H Seo; J-H Kim; S J Choi; J D Ji; Y H Lee
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

Review 3.  An update on the contribution of the MHC to AS susceptibility.

Authors:  John D Reveille
Journal:  Clin Rheumatol       Date:  2014-05-18       Impact factor: 2.980

Review 4.  Predisposing factors in the spondyloarthropathies: new insights into the role of HLA-B27.

Authors:  R A Colbert; S Prahalad
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

5.  HLA class I and II alleles in susceptibility to ankylosing spondylitis.

Authors:  John D Reveille; Xiaodong Zhou; MinJae Lee; Michael H Weisman; Lin Yi; Lianne S Gensler; Hejian Zou; Michael M Ward; Mariko L Ishimori; Thomas J Learch; Dongyi He; Mohammad H Rahbar; Jiucun Wang; Matthew A Brown
Journal:  Ann Rheum Dis       Date:  2018-10-19       Impact factor: 19.103

Review 6.  Behçet's Disease: Do Natural Killer Cells Play a Significant Role?

Authors:  Harry Petrushkin; Md Samiul Hasan; Miles R Stanford; Farida Fortune; Graham R Wallace
Journal:  Front Immunol       Date:  2015-03-24       Impact factor: 7.561

7.  Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.

Authors:  Qingwen Wang; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2015-11-24

8.  The Expression Levels of MicroRNAs Associated with T and B Cell Differentiation/stimulation in Ankylosing Spondylitis.

Authors:  A Türkyilmaz; P Ata; F Akbaş; İ Yağci
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.